Speakers
Key Opinion Leader: Vaughan Thomas, PhD – Bioprocess Consultant, Tillingbourne Consulting
Vaughan Thomas provides consultancy services to production operations on process alternatives, capacity analysis, and manufacturing options. Before setting up his company in 2010, Vaughan had been with SciTech Engineering for 6 years. He had previously held positions at Wellcome Biotech and ICI Pharmaceuticals, and as a Senior Engineer at Raytheon and Jacobs Engineering. His career in biotechnology design spans 30 years, encompassing fermentation development, technical support to purification operations, facility & process design, and start-up consultancy. During the COVID-19 pandemic, he acted as a technical advisor to the UK Vaccines Taskforce.
Vaughan Thomas holds undergraduate and doctorate degrees in Biochemical Engineering from University College London and is a Fellow of the Institution of Chemical Engineers. He is a Visiting Professor at UCL where he is also Outreach Manager for the Future Targeted Healthcare Manufacturing Hub.
Rob Olliver – Director, Process Sciences at Pharmaron Gene Therapy
Rob leads cGMP Production at Pharmaron and is the responsible person for Production and Warehousing. Over his 13+ years at the site, Rob has lead numerous cross functional operational improvements projects throughout the manufacturing facilities and the site. Rob has 20+ years experience in clinical & commercial manufacturing and has been instrumental in securing successful MHRA inspections. Rob is also a qualified Prince2 Practitioner.
Kieron McIntyre – Associate Director, Analytical Sciences at Pharmaron Gene Therapy
Kieron is the subject matter expert and responsible for managing analytical method validation and technology transfer across for Pharmaron Gene Therapy. In his role he leads cross functional teams and collaborates with strategic partners to drive technology transfer projects, from early state development through to registration with EMA, FDA and JNDA. With 13+ years experience within the pharmaceutical industry Kieron has a strong background in QC including acting as QC lead for successful MHRA inspections.
Richard Cooper – Associate Director, Project Engineering at Pharmaron Gene Therapy
Richard is a chartered Chemical and Biochemical Engineer with nearly 30 years experience in the pharmaceutical industry. In this time, he has developed core competences in Process Engineering/Safety, Program and Project Management by designing and implementing strategic and business critical engineering solutions in small molecule development, bulk API and biologics manufacturing. Currently Richard is the client lead and process subject matter expert for a new multi-million pound biologics site expansion project at Pharmaron’s Gene Therapy CDMO in Liverpool, UK.
Moderated by:
Derek Ellison, PhD – VP, Biologics Services Europe at Pharmaron Gene Therapy
